Inhibitors of fatty acid amide hydrolase
First Claim
1. A method of treating an FAAH-mediated disorder comprising administering to a subject in need thereof a therapeutically effective amount of compound of formula I:
0 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof, or mixtures thereof, wherein Z1, Z2, X1, X2, X3, R1, R2, R3, m and n are defined herein. Also provided are pharmaceutically acceptable compositions that include a compound of formula I and a pharmaceutically acceptable excipient. Also provided are methods for treating FAAH-mediated disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound or composition of the present invention.
-
Citations
57 Claims
- 1. A method of treating an FAAH-mediated disorder comprising administering to a subject in need thereof a therapeutically effective amount of compound of formula I:
- 46. The method of 45, wherein the pain disorder is selected from neuropathic pain, central pain, deafferentiation pain, chronic pain, stimulus of nociceptive receptors, acute pain, non-inflammatory pain, inflammatory pain, pain associated with cancer, preoperative pain, arthritic pain, lumbosacral pain, musculo-skeletal pain, headache, migraine, muscle ache, lower back and neck pain, and toothache.
Specification